These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25367939)

  • 1. The NOTCH pathway plays a tumor suppressive role in bladder cancer.
    Cancer Discov; 2014 Nov; 4(11):1252. PubMed ID: 25367939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH pathway inactivation promotes bladder cancer progression.
    Maraver A; Fernandez-Marcos PJ; Cash TP; Mendez-Pertuz M; Dueñas M; Maietta P; Martinelli P; Muñoz-Martin M; Martínez-Fernández M; Cañamero M; Roncador G; Martinez-Torrecuadrada JL; Grivas D; de la Pompa JL; Valencia A; Paramio JM; Real FX; Serrano M
    J Clin Invest; 2015 Feb; 125(2):824-30. PubMed ID: 25574842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4.
    Ai X; Jia Z; Liu S; Wang J; Zhang X
    Oncol Rep; 2014 Oct; 32(4):1459-64. PubMed ID: 25109409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer and the Notch pathway.
    Fernandez-Marcos PJ; Serrano M; Maraver A
    Oncotarget; 2015 Jan; 6(3):1346-7. PubMed ID: 25633811
    [No Abstract]   [Full Text] [Related]  

  • 5. A new tumor suppressor role for the Notch pathway in bladder cancer.
    Rampias T; Vgenopoulou P; Avgeris M; Polyzos A; Stravodimos K; Valavanis C; Scorilas A; Klinakis A
    Nat Med; 2014 Oct; 20(10):1199-205. PubMed ID: 25194568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling disparate roles of NOTCH in bladder cancer.
    Goriki A; Seiler R; Wyatt AW; Contreras-Sanz A; Bhat A; Matsubara A; Hayashi T; Black PC
    Nat Rev Urol; 2018 Jun; 15(6):345-357. PubMed ID: 29643502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective.
    Wang HT; Chang JW
    Histol Histopathol; 2005 Jan; 20(1):147-53. PubMed ID: 15578434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
    Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
    Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.
    Geisler F; Nagl F; Mazur PK; Lee M; Zimber-Strobl U; Strobl LJ; Radtke F; Schmid RM; Siveke JT
    Hepatology; 2008 Aug; 48(2):607-16. PubMed ID: 18666240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical applications of molecular biomarkers in urothelial carcinoma of bladder].
    Cheng L; Xu JW; He JJ; Zhao J; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):714-7. PubMed ID: 22321559
    [No Abstract]   [Full Text] [Related]  

  • 12. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner.
    Schouwey K; Delmas V; Larue L; Zimber-Strobl U; Strobl LJ; Radtke F; Beermann F
    Dev Dyn; 2007 Jan; 236(1):282-9. PubMed ID: 17080428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis.
    Kumano K; Masuda S; Sata M; Saito T; Lee SY; Sakata-Yanagimoto M; Tomita T; Iwatsubo T; Natsugari H; Kurokawa M; Ogawa S; Chiba S
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):70-8. PubMed ID: 18353145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
    Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
    APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different role of Notch1 and Notch2 in astrocytic gliomas.
    Xu P; Zhang A; Jiang R; Qiu M; Kang C; Jia Z; Wang G; Han L; Fan X; Pu P
    PLoS One; 2013; 8(1):e53654. PubMed ID: 23349727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic expression of Notch in melanocytes demonstrates RBP-Jkappa-dependent signaling.
    Schouwey K; Larue L; Radtke F; Delmas V; Beermann F
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):134-6. PubMed ID: 19895548
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.
    Hong D; Knelson EH; Li Y; Durmaz YT; Gao W; Walton E; Vajdi A; Thai T; Sticco-Ivins M; Sabet AH; Jones KL; Schinzel AC; Bronson RT; Nguyen QD; Tolstorukov MY; Vivero M; Signoretti S; Barbie DA; Oser MG
    Cancer Res; 2022 Jan; 82(2):248-263. PubMed ID: 34810201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
    Montironi R; Lopez-Beltran A; Cheng L
    Eur Urol; 2008 Oct; 54(4):843-4. PubMed ID: 18166261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.